XOLAIR

Serial Number 78296612
Registration 3086141
800

Registration Progress

Application Filed
Sep 5, 2003
Under Examination
Aug 3, 2004
Approved for Publication
Apr 21, 2004
Published for Opposition
May 11, 2004
Registered
Apr 25, 2006

Attorney Assistance

Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2006-04-25)
Due: Apr 25, 2026 264 days

Trademark Image

XOLAIR

Basic Information

Serial Number
78296612
Registration Number
3086141
Filing Date
September 5, 2003
Registration Date
April 25, 2006
Published for Opposition
May 11, 2004
Renewal Date
April 25, 2016
Drawing Code
1

Status Summary

Current Status
Active
Status Code
800
Status Date
Mar 30, 2016
Registration
Registered
Classes
005

Rights Holder

NOVARTIS AG

03
Address
CH-4002
Basel
CH

Ownership History

NOVARTIS AG

Original Applicant
03
Basel CH

NOVARTIS AG

Owner at Publication
03
Basel CH

NOVARTIS AG

Original Registrant
03
Basel CH

Legal Representation

Attorney
MAURY M. TEPPER III

USPTO Deadlines

Next Deadline
264 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2006-04-25)
Due Date
April 25, 2026
Grace Period Ends
October 25, 2026

Application History

33 events
Date Code Type Description Documents
Apr 25, 2025 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Mar 30, 2016 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Mar 30, 2016 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Mar 30, 2016 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Mar 30, 2016 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 21, 2016 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Apr 25, 2015 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Sep 9, 2011 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Sep 9, 2011 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Sep 9, 2011 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Aug 2, 2011 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jun 27, 2009 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 27, 2009 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 25, 2006 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 8, 2006 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED Loading...
Mar 3, 2006 ALIE A ASSIGNED TO LIE Loading...
Mar 1, 2006 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 28, 2006 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 2, 2006 IUAF S USE AMENDMENT FILED Loading...
Feb 2, 2006 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 2, 2005 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 2, 2005 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 2, 2005 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 14, 2005 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 28, 2005 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 28, 2005 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 4, 2004 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 18, 2004 MAIL I PAPER RECEIVED Loading...
Aug 3, 2004 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 11, 2004 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 21, 2004 NPUB O NOTICE OF PUBLICATION Loading...
Mar 8, 2004 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 8, 2004 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of IgE-mediated disorders
First Use Anywhere: Dec 31, 2003
First Use in Commerce: Dec 31, 2003

Classification

International Classes
005